Stem Cell Therapy for Multiple Sclerosis
In recent clinical trials, umbilical cord allograft stem cells were found to not only be effective in treating symptoms of multiple sclerosis but were found to be safe and even lead to sustained improvements in disability and brain lesions. This report was released on March 20th, 2018 on the website Multiple Sclerosis News Today. The original article titled, “Clinical feasibility of umbilical cord tissue-derived mesenchymal allograft stem cells in the treatment of multiple sclerosis” was published in the Journal of Translational Medicine in January of 2018. Current treatments of MS, while able to reduce the frequency of flare-ups and slow disease progression, are not able to repair damage to nerve cells or the protective layer around nerve fibers known as the myelin sheath. As we discussed in our article, “Not All Stem Cells Are Created Equal”, allograft stem cells must at least be multipotent in order to have the ability to differentiate into multiple cell types. Mesenchymal stem cells, or MSCs,...
